Entity Common Stock, Shares Outstanding of Viking Therapeutics, Inc. from 10 Jun 2015 to 31 Jan 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Viking Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 10 Jun 2015 to 31 Jan 2026.
  • Viking Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 31 Jan 2026 was 115,554,295, a 2.9% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Viking Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 115,554,295 +3,306,486 +2.9% 31 Jan 2026 10-K 11 Feb 2026 2025 FY
Q3 2025 113,036,344 +1,599,960 +1.4% 15 Oct 2025 10-Q 23 Oct 2025 2025 Q3
Q2 2025 112,444,961 +1,648,761 +1.5% 15 Jul 2025 10-Q 23 Jul 2025 2025 Q2
Q1 2025 112,309,545 +2,041,335 +1.9% 15 Apr 2025 10-Q 24 Apr 2025 2025 Q1
Q4 2024 112,247,809 +11,759,470 +12% 31 Jan 2025 10-K 26 Feb 2025 2024 FY
Q3 2024 111,436,384 +11,407,431 +11% 15 Oct 2024 10-Q 23 Oct 2024 2024 Q3
Q2 2024 110,796,200 +10,767,372 +11% 15 Jul 2024 10-Q 24 Jul 2024 2024 Q2
Q1 2024 110,268,210 +10,686,517 +11% 15 Apr 2024 10-Q 25 Apr 2024 2024 Q1
Q4 2023 100,488,339 +22,069,810 +28% 31 Jan 2024 10-K 07 Feb 2024 2023 FY
Q3 2023 100,028,953 +23,340,475 +30% 15 Oct 2023 10-Q 25 Oct 2023 2023 Q3
Q2 2023 100,028,828 +23,340,350 +30% 15 Jul 2023 10-Q 26 Jul 2023 2023 Q2
Q1 2023 99,581,693 +22,207,981 +29% 15 Apr 2023 10-Q 26 Apr 2023 2023 Q1
Q4 2022 78,418,529 +55,625 +0.07% 31 Jan 2023 10-K 10 Feb 2023 2022 FY
Q3 2022 76,688,478 -1,546,411 -2% 15 Oct 2022 10-Q 26 Oct 2022 2022 Q3
Q2 2022 76,688,478 -1,501,336 -1.9% 15 Jul 2022 10-Q 27 Jul 2022 2022 Q2
Q1 2022 77,373,712 -726,456 -0.93% 15 Apr 2022 10-Q 27 Apr 2022 2022 Q1
Q4 2021 78,362,904 +4,229,783 +5.7% 31 Jan 2022 10-K 09 Feb 2022 2021 FY
Q3 2021 78,234,889 +5,282,917 +7.2% 15 Oct 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 78,189,814 +5,431,472 +7.5% 15 Jul 2021 10-Q 28 Jul 2021 2021 Q2
Q1 2021 78,100,168 +5,503,720 +7.6% 15 Apr 2021 10-Q 28 Apr 2021 2021 Q1
Q4 2020 74,133,121 +1,570,258 +2.2% 31 Jan 2021 10-K 17 Feb 2021 2020 FY
Q3 2020 72,951,972 +688,456 +0.95% 15 Oct 2020 10-Q 28 Oct 2020 2020 Q3
Q2 2020 72,758,342 +547,712 +0.76% 15 Jul 2020 10-Q 29 Jul 2020 2020 Q2
Q1 2020 72,596,448 +548,791 +0.76% 15 Apr 2020 10-Q 30 Apr 2020 2020 Q1
Q4 2019 72,562,863 31 Jan 2020 10-K 26 Feb 2020 2019 FY
Q3 2019 72,263,516 +803,659 +1.1% 31 Oct 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 72,210,630 +11,552,836 +19% 31 Jul 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 72,047,657 +21,114,462 +41% 30 Apr 2019 10-Q 02 May 2019 2019 Q1
Q3 2018 71,459,857 +42,961,010 +151% 31 Oct 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 60,657,794 +32,960,510 +119% 31 Jul 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 50,933,195 +27,007,770 +113% 30 Apr 2018 10-Q 09 May 2018 2018 Q1
Q3 2017 28,498,847 +8,328,583 +41% 31 Oct 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 27,697,284 +8,419,633 +44% 31 Jul 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 23,925,425 +4,656,684 +24% 30 Apr 2017 10-Q 10 May 2017 2017 Q1
Q3 2016 20,170,264 +10,491,952 +108% 31 Oct 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 19,277,651 +9,494,339 +97% 31 Jul 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 19,268,741 29 Apr 2016 10-Q 10 May 2016 2016 Q1
Q3 2015 9,678,312 02 Nov 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 9,783,312 10 Jun 2015 10-Q 12 Jun 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.